Report Library
All Reports
Informa Post-ASCO 2015 Webinar
June 05, 2015
Following the conclusion of this year's ASCO conference, Informa’s analysts have gathered once again to discuss the key takeaways
from this year’s conference, assess its winners and losers, and examine the implications for the future of the oncology treatment
landscape.
The session was hosted by Mary Jo Laffler, Bureau Chief, Clinical Development and Business Coverage for industry-leading
publication ‘The Pink Sheet’. She was joined by the following analysts:
- Joseph Hedden, Senior Analyst in Oncology for Datamonitor Healthcare
- Rachel Meighan-Mantha, Principal Analyst in Oncology for Citeline
- Edny Inui, Senior Scientific Analyst for BioMedTracker and Product Manager for KOL Insight, and
- Robert Jeng, Senior Scientific Analyst for BioMedTracker
ASCO 2015: Post-Conference Review from Datamonitor Healthcare on Vimeo.
This webinar discussing post-conference highlights is an Informa product and not an official product of the 2015 ASCO meeting or the ASCO organization. A free recording of this webinar for non-BioMedTracker clients is available from the Datamonitor Heathcare website. For our disclosures, please read the BioMedTracker Research Standards.| Disease Group Covered: | Oncology |
| Indications Covered: | Castleman's Disease |
Additional Resources: